Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine versus sufentanil with ciprofol for anesthesia in day-case hysteroscopy
ChiCTR2600132928Phase 4Not yet recruiting
- Sponsor
- The People's Hospital of Suzhou Gaoxin District
- Start
- Sep 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tegileridine, sufentanil and ciprofol in gynaecological conditions (2 arms), sponsored by The People's Hospital of Suzhou Gaoxin District. Primary endpoint: Mild oxygen saturation reduction. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tegileridinesufentanilciprofol
03
Conditions
gynaecological conditions
Beyond the preview
Go deeper on ChiCTR2600132928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132928.